Investigation of the difference among long acting insulin products in type 1 diabetes
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
Price : $35 *
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Best-Basal-Insulin-Study
- 05 Jun 2015 Results published in the Diabetologia.
- 19 Sep 2014 Primary endpoint (Standard deviation and coefficient of variation of fasting glucose level in the last week of treatment) has been met.
- 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.